International Stem Cell (ISCO) Stock Chart & Stock Price History $0.13 0.00 (0.00%) As of 08/8/2025 Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock International Stem Cell Stock Price Performance The International Stem Cell (ISCO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 91.50%, with a year-to-date return of 53.87%. In the past month, the stock has decreased 33.46%, reflecting recent market activity. As of the latest close, International Stem Cell traded at $0.13 with a market cap of $1.00 million and volume of 0 shares. Five years ago, the stock traded at $0.63, representing a 80.14% decrease over that period. At the time, it had a market cap of $4.75 million and a volume of 843 shares. Receive ISCO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for International Stem Cell and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance-33.46%3 Month Performance+13.73%Year-To-Date Performance+53.87%1 Year PerformanceN/A5 Year Performance-80.14% ISCO Stock Chart for Sunday, August, 10, 2025 ISCO Chart by TradingView International Stem Cell Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/06/2025$0.13$0.13$0.13$0.13112 shs$1.00 million08/05/2025$0.13$0.13$0.13$0.13112 shs$1.00 million08/04/2025$0.16$0.13-22.35%$0.13$0.13112 shs$1.00 million08/01/2025$0.20$0.16-18.22%$0.20$0.161,968 shs$1.29 million07/31/2025$0.15$0.20+34.93%$0.20$0.133,728 shs$1.58 million07/30/2025$0.15$0.15-0.48%$0.15$0.151,615 shs$1.17 million07/29/2025$0.20$0.15-25.53%$0.15$0.15107 shs$1.17 million07/28/2025$0.15$0.20+30.38%$0.20$0.131,735 shs$1.21 million07/25/2025$0.15$0.15$0.15$0.15100 shs$1.21 million07/24/2025$0.18$0.15-16.06%$0.15$0.15100 shs$1.21 million Get the Latest News and Ratings for ISCO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for International Stem Cell and its competitors with MarketBeat's FREE daily newsletter. 07/23/2025$0.13$0.18+38.46%$0.20$0.131,138 shs$1.44 million07/22/2025$0.15$0.13-13.91%$0.13$0.122,830 shs$1.04 million07/21/2025$0.15$0.15$0.17$0.1516,386 shs$1.21 million07/18/2025$0.20$0.15-23.74%$0.17$0.1516,386 shs$1.21 million07/17/2025$0.16$0.20+20.73%$0.20$0.124,741 shs$1.58 million07/16/2025$0.15$0.16+8.54%$0.18$0.161,192 shs$1.31 million07/15/2025$0.18$0.15-15.11%$0.20$0.1520,052 shs$1.21 million07/14/2025$0.12$0.18+48.33%$0.20$0.181,400 shs$1.42 million07/11/2025$0.19$0.12-36.17%$0.27$0.1237,027 shs$960,000.0007/10/2025$0.18$0.19+4.44%$0.19$0.174,250 shs$1.51 million07/09/2025$0.13$0.18+41.40%$0.19$0.1272,974 shs$1.44 million Related Companies Ensysce Biosciences Stock Chart Xenetic Biosciences Stock Chart Palisade Bio Stock Chart Intellipharmaceutics International Stock Chart Briacell Therap Stock Chart Sonoma Pharmaceuticals Stock Chart Adial Pharmaceuticals Stock Chart VivoSim Labs Stock Chart InMed Pharmaceuticals Stock Chart Mainz Biomed Stock Chart Receive ISCO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for International Stem Cell and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:ISCO) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredChina's 500 Million Year AdvantageThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Stem Cell Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share International Stem Cell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ISCO Stock Alerts